Interview with AegirBio CEO Mr Marco Witteveen
AegirBio CEO, Marco Witteveen, recently conducted an interview in Stockholm on the company's current position and strategic outlook.During the interview, Mr. Witteveen emphasized the pivotal juncture the company finds itself in, asserting that the leadership team has a clear vision of the path ahead. The company is set on a course focused on the market opportunities in Therapeutic Drug Monitoring and Oral Health. These areas, he stressed, not only hold significant clinical, operational, and economic potential but also promise to enhance the offerings available in today's market. Mr.